Promoting Health Equity via Translational Science: Bridging the Gap on Outcomes Influenced by Social Determinants of Health

Join us on a critically important voyage into the realm of Translational Science, paying tribute to the enduring legacy of David Seldin. Over the day, you’ll engage with dedicated researchers passionate about health equity, fostering community engagement, and transcending the challenges posed by social determinants of health. This event will serve as a platform for multidisciplinary collaboration and networking between researchers, community-based investigators, and concerned patients and citizens. As part of this journey, watch this clip about Brandon Tilghman’s Insights: Why Research Matters to Him and Our Community?

Below, explore our dynamic agenda, meet our esteemed speakers, peruse thought-provoking poster abstracts, and immerse yourself in the wealth of resources and opportunities offered by the Clinical and Translational Science Institute (CTSI). Discover how David Seldin’s vision continues to guide us towards a future where health equity is a reality for all. 

The 11th Annual CTSI Translational Science Symposium
  • Dynamic Agenda
  • Warm greetings by Megan Bair-Merritt, MD, MSCE, Boston Medical Center’s Chief Scientific Officer & BU CTSI MPI
  • Engaging & Dynamic Moderators:
  1. Chris Shanahan MD, MPH, Clinical Associate Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine.
  2. Natalia Morone, MD, MS, Associate Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine.
  3. Frederick L. Ruberg, MD, Professor of Cardiovascular Medicine at Boston University Chobanian & Avedisian School of Medicine.
  • Closing insights by David Center, MD, Gordon and Ruth Snider Professor of Pulmonary Medicine and Chief of Pulmonary, Allergy, Sleep, and Critical Care Medicine & BU CTSI MPI.
  • Keynote Speaker & Speakers Bios: Meet our esteemed speakers.
  • Poster Session and Community Resource Table: Time of poster session: 11:30 am – 12:25 pm
    Members of the Advancing Equity in Health Research Community Advisory Board (CAB) and BHN Research Collaborative will be present to explore opportunities for BU/BMC researchers to engage with the community on their projects.
  • Explore Poster Abstracts: View the poster presentations here.
Extend the conversation beyond the event:

Join the event discussion on Twitter (  ) using the hashtag: #BUCTSI_HealthEquity. Engage with fellow attendees, share your insights, and be part of the vibrant symposium dialogue. Let’s connect, learn, and collaborate for a brighter future in translational science! (Explore our Social Media Toolkit.)

Embrace the Future of Research with CTSI
  • CTSI Offerings & Resources: Operating within the CTSI grant cycle, our programs, and awards are tailored to empower researchers year-round, from April 1st to March 31st, aligning with our commitment to transformative scientific breakthroughs.
  • The Research Navigator TeamDiscover your path to success. Members of the BU CTSI Research Navigator Team (RNT) can provide guidance, linkages, resources, and concierge services to all investigators and their research teams for every stage of their translational research from planning to dissemination of findings
Discover the Legacy of Dr. David Seldin

In Grateful Recognition

Dr. David Seldin was a founding member of the BU CTSI in 2008. He made critical contributions to our Core Facilities program instituting a highly innovative core voucher system to subsidize usage. He is likely best remembered for organizing this annual Translational Science Symposium. Every part of the day bears his signature, from the idea itself, to the types of speakers, poster sessions and venue. We are deeply indebted to him for his vision and his wisdom. We hope that holding these annual symposia in his memory transmits even a small part of his sincere love of science and we hope everyone enjoys the day. He always wanted it to be fun.  

Dr. David Seldin was a Professor of Medicine and Microbiology at Boston University School of Medicine. He became Director of the Amyloidosis Center in 2007 and Chief of the Section of Hematology-Oncology in 2008. His research interests were cancer and blood disorders, particularly the light chain form of amyloidosis.


Let’s join hands to continue Dr. Seldin’s legacy of excellence and innovation in the world of Translational Science! Together, we can make a difference!

  • Ways to Contribute:
    1. The David C. Seldin, M.D., Ph.D. Professorship in Medicine or
    2. The David C. Seldin M.D, Ph.D. Amyloid Research Training Fund
  • How to Contribute:
    To make your contribution in Dr. Seldin’s memory, reach out to the BUSM Development Office:
    📞 Call: 617-638-4570 📧 Email: busmdev@bu.edu

Banner Photo Credit: Courtesy of the National Center for Advancing Translational Science (NCATS)